Study reveals insights into DDX41 protein's role in blood cancer pathogenesis
Medical Xpress » Cancer News
by
14h ago
A study led by Professors Hongtae Kim and JaYil Lee from the Department of Biological Sciences, in collaboration with researchers from the Catholic University of Korea, sheds light on the pivotal role of mutated DDX41 protein in the pathogenesis of Myelodysplastic Syndrome (MDS), a form of blood cancer ..read more
Visit website
Liver cancer: Molecular signaling pathway of tumor development decoded
Medical Xpress » Cancer News
by
14h ago
As a malignant disease of the liver cells, hepatocellular carcinoma (HCC) is one of the main causes of cancer-related deaths. While the treatment options for this aggressive type of cancer remain limited, the incidence is increasing ..read more
Visit website
A sustainable diagnosis tool for multiple cancers
Medical Xpress » Cancer News
by
14h ago
An accurate, affordable, environmentally and user-friendly diagnostic tool for multiple cancers—including pancreatic, gastric, and colorectal cancers—is reported in a paper in Nature Sustainability. The tool can diagnose cancers within minutes and could help to address the need for accessible diagnostic tools, especially in remote areas ..read more
Visit website
Improving cancer immunotherapy by prolonging T-cell survival
Medical Xpress » Cancer News
by
1d ago
In the past decade, immunotherapy has emerged as the fourth pillar of cancer treatment, joining surgery, radiotherapy and chemotherapy. It is an approved treatment for 15 cancers, including melanoma and some types of lymphomas and leukemias, but it is not effective in all cancers or in all patients ..read more
Visit website
Genetically engineering a treatment for incurable brain tumors
Medical Xpress » Cancer News
by
2d ago
Purdue University researchers are developing and validating a patent-pending treatment for incurable glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time of 14 months. Traditional methods used against other cancers, like chemotherapy and immunotherapy, are often ineffective on glioblastoma ..read more
Visit website
Hitchhiking of synthetic antigen stimulates antibody production against cancer cells
Medical Xpress » Cancer News
by
2d ago
Researchers at the Indian Institute of Science (IISc) have designed a synthetic compound (antigen) that can latch on to a protein in blood and hitchhike a ride to the lymph node, where it can boost the production of antibodies against cancer cells ..read more
Visit website
Expert reviews the current state of retinoblastoma research
Medical Xpress » Cancer News
by
2d ago
Retinoblastoma is a rare pediatric cancer, with approximately 250–300 new cases per year in the United States and 8,000 worldwide. The cancer grows within the retina, a thin layer of cells at the back of the eye, and is usually treatable when diagnosed early. However, if undiagnosed, retinoblastoma can metastasize and lead to death ..read more
Visit website
Researchers develop a new way to safely boost immune cells to fight cancer
Medical Xpress » Cancer News
by
5d ago
Last year alone, more than 600,000 people in the United States died from cancer, according to the American Cancer Society. The relentless pursuit of understanding this complex disease has shaped medical progress in developing treatment procedures that are less invasive while still highly effective ..read more
Visit website
Using AI to trace the origins of metastatic cancer cells
Medical Xpress » Cancer News
by
5d ago
A large team of cancer researchers affiliated with several institutions in China, working with a pair of colleagues in the U.S., has found that artificial intelligence applications can be used to trace the origins of metastatic cancer cells in remote parts of the body ..read more
Visit website
Study of cancer-induced liver inflammation finds a promising therapeutic target
Medical Xpress » Cancer News
by
5d ago
Liver inflammation, a common side-effect of cancers elsewhere in the body, has long been associated with worse cancer outcomes and more recently associated with poor response to immunotherapy. Now, a team led by researchers from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania has found a big reason why ..read more
Visit website

Follow Medical Xpress » Cancer News on FeedSpot

Continue with Google
Continue with Apple
OR